Clinical Trial Update: Somatostatin in Living Donor Liver Transplantation [Phase 4]

View source ↗

Summary

Clinical trial update for somatostatin in living donor liver transplantation (Phase 4) with unknown status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Liver Disease
• Portal Hypertension

Drugs mentioned

• Somatostatin (somatostatin)

Snippet

Sponsor: King Faisal Specialist Hospital & Research Center | Conditions: End Stage Liver DIsease, Portal Hypertension | Phase 4 | Status: UNKNOWN